FEMY News and Press, Femasys Inc. From 11/09/23

Histogen Inc. (HSTO) is expected to report for Q3 2023 News Corporation (NWSA) is expected to report $0.13 for Q1 2024 TORM plc (TRMD) is expected to report for Q3 2023 Blink Charging Co. (BLNK) is expected to report $-0.47 for Q3 2023 Nuvalent Inc. (NUVL) is expected to report $-...

Femasys Inc. (FEMY) is expected to report $-0.25 for Q3 2023

– Completion of the European Union Medical Device Regulation (MDR) final audit is the last step in obtaining an MDR certificate and CE marking, confirming Femasys’ compliance with the highest required regulatory standards – – Femasys continues to fulfill its co...

2023-10-25 09:56:07 ET More on Femasys Femasys regains Nasdaq compliance Seeking Alpha’s Quant Rating on Femasys Historical earnings data for Femasys Financial information for Femasys For further details see: Femasys to showcase FemBloc, ot...

ATLANTA, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of in-office, accessible solutions, including a lead late-clinical stage product candidate and innovative diagnostic p...

2023-10-12 13:26:41 ET More on Femasys, Jaguar Health, etc. Jaguar Health, Inc. (JAGX) Q2 2023 Earnings Call Transcript LogicMark, Inc. (LGMK) Q2 2023 Earnings Call Transcript Femasys regains Nasdaq compliance Jaguar Health's Napo Pharma gets patent in Japan ...

2023-10-11 07:49:58 ET More on Femasys Seeking Alpha’s Quant Rating on Femasys Historical earnings data for Femasys Financial information for Femasys For further details see: Femasys regains Nasdaq compliance

ATLANTA, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (Nasdaq: FEMY), a biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of in-office, accessible solutions, including a lead late-clinical stage product candidate and innovative diagnostic p...

2023-10-10 08:23:35 ET More on Longeveron Longeveron: Alzheimer's Phase 2 Data Around The Corner Longeveron Inc. (LGVN) Q2 2023 Earnings Call Transcript Longeveron falls after mid-stage data for Alzheimer’s candidate Longeveron announces pricing for ri...

2023-10-06 15:43:10 ET DENVER, Colo., Oct 6, 2023 ( www.247marketnews.com )- The following companies were among the listings that we covered this week; IceCure Medical Ltd. (NASDAQ: ICCM), Femasys (NASDAQ: FEMY), SeaStar Medical Holding (NASDAQ: ICU), Siyata Mobile (NASDAQ: SYTA), Vivos...